All enrolled patients completed 3-month follow-up after admission. Eighty-five patients (26.4%) experienced ND within 10 days after admission. The median (interquartile range) time to ND from the time of first National Institutes of Health Stroke Scale score assessment was 22 (5.3-29) hours. In 61 out of the 85 patients (71.8%), ND was observed within the first 24 hours after admission. Baseline characteristics and the mean 20-HETE levels in patients with or without ND are summarized in Table I in the online-only Data Supplement. One hundred and seventy-seven patients had atherothrombotic
N eurological deterioration (ND) is a common occurrence in patients with minor ischemic stroke (MIS)
. 1 An understanding of the basic mechanisms involved in ND could provide valuable insights for prevention and treatment of ND. Arachidonic acid is metabolized by cytochrome P450 ω-hydroxylase enzymes to form 20-hydroxyeicosatetraenoic acid (20-HETE). Production of 20-HETE in the cerebral vasculature was shown to be correlated with the severity of stroke. 2 Experimental evidence suggests that 20-HETE may cause endothelial dysfunction through various mechanisms. 3 In our previous studies, we demonstrated an association of elevated plasma 20-HETE levels with plaque instability and carotid stenosis, both of which are independent risk factors for ischemic stroke. 4, 5 However, whether high 20-HETE level is a risk factor for ND in patients with acute MIS has not been studied. The purpose of this study was to assess the potential association of 20-HETE levels with ND in Chinese patients with MIS.
Methods
Detailed methods are provided in the online-only Data Supplement.
This was a prospective multicenter study. A total of 322 consecutive patients with MIS who had their first stroke and were hospitalized within 24 hours of the onset of stroke were enrolled. MIS was defined as National Institutes of Health Stroke Scale score of ≤3 points at admission. In all cases, the cause of stroke in MIS was because of atherothrombotic or small artery disease.
Plasma 20-HETE levels were measured at admission in all patients. The primary outcome of this study was neurological deterioration, defined as increase in National Institutes of Health Stroke Scale score by ≥2 points within 10 days after admission. 6 The secondary outcome was a composite of recurrent ischemic stroke, myocardial infarction, and death during the first 3 months after admission. The degree of disability was measured using modified Rankin Scale (modified Rankin scale) at 3 months after admission.
We examined total 20-HETE by increasing quartiles to evaluate for possible threshold effects. Baseline and clinical characteristics were compared using χ 2 test or the Student t test. Variables that showed a significant association (P<0.1) with ND on univariate analysis were included in the multivariate logistic regression model. Increased 20-HETE levels showed a significant correlation with age, hypertension, ND, and modified Rankin scale score at 3 months. However, there was no significant association between 20-HETE levels and secondary outcome (Table II in  the online-only Data Supplement). 20-HETE, fasting glucose, and hemoglobin A1c levels were found to be independent predictors of ND. The odds ratio for ND increased with increase in quartiles of 20-HETE level, using the lowest quartile as the reference value. The third and fourth highest quartiles of 20-HETE levels were found to be independent predictors of ND (Table) . Cox proportional hazard curve showed an increase in the risk for ND with higher levels of 20-HETE (Figure) . Spearman rank-order correlation showed a significant association between 20-HETE levels and modified Rankin scale score at 3 months (P<0.001). Patients who deteriorated had a higher risk for poor outcome (modified Rankin scale scores 3-6) after adjusting for age, diabetes mellitus, fasting glucose (relative risk: 1.82; 95% confidence interval, 1.46-2.35; P=0.024).
Discussion
In this study, ND was fairly common in patients with acute MIS and was associated with poor functional outcomes. Elevated 20-HETE levels were associated with ND, and the risk of ND tended to increase with increase in the levels of 20-HETE. This study is the first to report a positive correlation between 20-HETE levels and ND.
In a previous study, 20-HETE was shown to cause vasoconstriction in the cerebral arteries and to regulate cerebral vascular tone by activating intracellular signaling pathways that are involved in apoptosis and cell death.
7 20-HETE was also shown to depolarize vascular smooth muscle cells through inhibition of large-conductance calcium-sensitive potassium channels. 8 Finally, 20-HETE was shown to promote the formation of oxygen radicals 2 and cause endothelial dysfunction. 3 Inhibition of the synthesis of 20-HETE has been shown to reduce infarct size after transient cerebral ischemia. 9 All these findings suggest a potential molecular mechanism that links 20-HETE with risk of functional disability. Once deterioration occurred, there are no effective therapies to arrest it. Thus, prevention of ND is a key imperative. 20-HETE promotes the formation of oxygen radicals and may contribute to the pathogenesis of ND. 2 Ciccone et al 10 proposed a role of carotenoids supplementation in cardiovascular disease, because of their free-radical-scavenging properties. However, it is not clear whether supplementation of carotenoids has a preventive effect on ND. Further studies are needed to determine this.
In some studies, the degree of carotid stenosis and middle cerebral artery occlusion have been shown to be associated with ND. 11, 12 In the present study, we did not observe such an association. Our results were consistent with one recent study. 13 However, these findings must be validated in larger, multicenter studies in future.
Our study has several limitations. First, some studies have shown the association of biomarkers such as high-sensitive C-reactive protein, inflammatory cytokines, and brain natriuretic peptide with ND. However, these biomarkers were not measured in this study, and we did not eliminate effect of these biomarkers on ND. Second, 20-HETE levels may change dynamically after ischemic stroke 14 and may be affected by ischemia itself and aspirin. In this study, plasma 20-HETE levels were measured within 24 hours of onset and before aspirin treatment. We did not investigate effect of acute ischemia itself and aspirin on 20-HETE levels. Further studies are needed to evaluate the association between dynamic changes of 20-HETE levels and ND. Finally, the lack of a control group in the present study is a study limitation. Thus, well-designed studies are needed to validate our findings in future. 
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In this study, elevated 20-HETE levels were significantly associated with ND. Given the association of ND with poor functional outcomes, 20-HETE level may be a valuable predictor of prognosis in patients with acute MIS.
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Supplemental Information

Methods
Study population
This prospective multi-center study was conducted in the People's Hospital of Deyang 
Carotid ultrasonography
We performed duplex scans in duplicate with the Acuson Sequoia Apparatus type 512 (7.5-MHz probe, Berlin, Germany). Bilateral internal and common carotid arteries, as well as their bifurcations were examined for presence of atherosclerotic plaque, echolucent plaque or echogenic plaque, and degree of stenosis, as described elsewhere. 3, 4 The coefficients of intra-observer and inter-observer variations for the degree of stenosis were 7.4% and 7.8%, respectively. 3 Intra-observer and inter-observer coefficients of variation for plaque echogenicity were 8.2% and 8.8%, respectively.
4
Measurement of plasma 20-HETE levels
Whole blood samples (4 mL) were drawn from all patients at admission and transferred to a sterile tube containing ethylenediaminetetraacetic acid (EDTA)/butylated hydroxytoluene (BHT)/glutathione. Plasma was isolated following centrifugation and samples were stored at −80°C until analysis. Plasma 20-hydroxyeicosatetraeonic acid (20-HETE) levels were measured using a stable isotope dilution gas chromatography/mass spectrometer (GC/MS), as described elsewhere. 3, 4 Validity and reproducibility of plasma 20-HETE levels has been established.
3,4
Assessment of clinical outcomes
The primary outcome of this study was neurological deterioration (ND), which was defined as an increase in NIHSS score by ≥ 2 points within 10 days after admission, after exclusion of hemorrhagic transformation of infarct or a new infarct in another vascular territory. 5 The neurological status of the patients was assessed by trained neurologists on a daily basis. The secondary outcome was a composite of recurrent ischemic stroke (RIS), MI and death during the first 3 months after admission.
Recurrent ischemic stroke was defined as a new focal neurologic deficit of vascular origin lasting at least 24 h, diffusion weighted imaging (DWI)-positive lesion(s)
which corresponded to their clinical symptom(s) and proven to be non-hemorrhagic.
Death was defined as vascular mortality due to MI, ischemic stroke, or other vascular causes. The degree of disability was measured using modified Rankin Scale (mRS) at 6 defined as mRS ≤ 2 points, while a mRS > 2 point was considered as a poor outcome.
During the 3-month treatment, interviews were conducted every month by investigators who were blinded to 20-HETE levels of the patient. After discharge, scheduled follow-up telephone calls were made biweekly to encourage compliance, to answer any queries, and to document any side effects.
Hospital treatment
All patients received standard therapy based on the guidelines, 6 including clopidogrel 
Statistical analyses
Up to 20%-40% of all patients with MIS reportedly develop ND. Using this estimate,
we calculated a minimum sample-size requirement of 310 patients for determining the true incidence rate within ± 15% with 95% confidence. 7 We examined total 20-HETE by increasing quartiles levels to evaluate for a possible threshold effects. Baseline and clinical characteristics were compared using χ 2 test or Fisher exact test (categorical variables) and the Student t test (continuous variables). Variables that showed a significant association (P < 0.1) with ND on univariate analysis were included in the multivariate logistic regression model. Cox proportional hazard model was used to assess the probability of ND according to the 20-HETE tertiles. All tests were two sided, and the threshold level of P < 0.05 denoted statistical significance. All statistical analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Death during 3 months (n, %) 1 (0.6) 1 (0.6) 0.999 HETE, hydroxyeicosatetraenoic acid; ND, neurological deterioration ; NIHSS, National Institutes of Health Stroke Scale; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; HbA1c, hemoglobin A1c; tPA, tissue plasminogen activator; RIS, recurrent ischemic stroke; MI, myocardial infarction.
Supplemental Tables
LDL-C (mmol/L) 2.9 ± 0.
